These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23141815)

  • 1. RELAX-AHF: rising from the doldrums in acute heart failure.
    Konstam MA
    Lancet; 2013 Jan; 381(9860):5-6. PubMed ID: 23141815
    [No Abstract]   [Full Text] [Related]  

  • 2. Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence.
    Ghosh RK; Banerjee K; Tummala R; Ball S; Ravakhah K; Gupta A
    Cardiovasc Ther; 2017 Feb; 35(1):55-63. PubMed ID: 27727514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The RELAX-AHF study].
    Mortara A
    G Ital Cardiol (Rome); 2015 Apr; 16(4):193-7. PubMed ID: 25959752
    [No Abstract]   [Full Text] [Related]  

  • 4. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
    Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
    Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serelaxin : a potential new drug for the treatment of acute heart failure.
    Neverova N; Teerlink JR
    Expert Opin Investig Drugs; 2014 Jul; 23(7):1017-26. PubMed ID: 24865798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serelaxin a novel treatment for acute heart failure.
    Castrini AI; Carubelli V; Lazzarini V; Bonadei I; Lombardi C; Metra M
    Expert Rev Clin Pharmacol; 2015; 8(5):549-57. PubMed ID: 26294074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted biological therapies reach the heart: the case of serelaxin for heart failure.
    Kumar VA; Wilson SS; Ayaz SI; Levy PD
    Drugs Today (Barc); 2015 Oct; 51(10):591-7. PubMed ID: 26583301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Representativeness of RELAX-AHF clinical trial population in acute heart failure.
    Wang TS; Hellkamp AS; Patel CB; Ezekowitz JA; Fonarow GC; Hernandez AF
    Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):259-68. PubMed ID: 24594552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serelaxin and acute heart failure.
    Tietjens J; Teerlink JR
    Heart; 2016 Jan; 102(2):95-9. PubMed ID: 26603680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of the RELAXin in acute heart failure study.
    Ponikowski P; Metra M; Teerlink JR; Unemori E; Felker GM; Voors AA; Filippatos G; Greenberg B; Teichman SL; Severin T; Mueller-Velten G; Cotter G; Davison BA
    Am Heart J; 2012 Feb; 163(2):149-55.e1. PubMed ID: 22305830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study.
    Felker GM; Teerlink JR; Butler J; Hernandez AF; Miller AB; Cotter G; Davison BA; Filippatos G; Greenberg BH; Ponikowski P; Voors AA; Hua TA; Severin TM; Unemori E; Metra M
    J Am Coll Cardiol; 2014 Oct; 64(15):1591-8. PubMed ID: 25301463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial.
    Pang PS; Teerlink JR; Boer-Martins L; Gimpelewicz C; Davison BA; Wang Y; Voors AA; Severin T; Ponikowski P; Hua TA; Greenberg BH; Filippatos G; Felker GM; Cotter G; Metra M
    Am Heart J; 2017 May; 187():62-69. PubMed ID: 28454809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF.
    Liu LC; Voors AA; Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Chen Y; Greenberg BH; Ponikowski P; Pang PS; Prescott MF; Hua TA; Severin TM; Metra M
    Clin Res Cardiol; 2016 Sep; 105(9):727-37. PubMed ID: 27017514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of serelaxin in acute heart failure.
    Du XJ; Hewitson TD; Nguyen MN; Samuel CS
    Circ J; 2014; 78(3):542-52. PubMed ID: 24451687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human relaxin-2: (how) can a pregnancy hormone save lives in acute heart failure?
    Dschietzig TB
    Am J Cardiovasc Drugs; 2014 Oct; 14(5):343-55. PubMed ID: 24934696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
    Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
    Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR;
    J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond.
    Cotter G; Milo O; Davison BA
    Curr Heart Fail Rep; 2014 Mar; 11(1):19-30. PubMed ID: 24363020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions.
    Díez J
    Am J Cardiovasc Drugs; 2014 Aug; 14(4):275-85. PubMed ID: 24590581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of serelaxin in the therapeutic armamentarium for heart failure.
    Varr BC; Maurer MS
    Curr Atheroscler Rep; 2014 Oct; 16(10):447. PubMed ID: 25108571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.